Debates & Insight
Debates/ Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand
Launch excellence in a disrupted world – challenges & opportunities
louise.bellamy@pharmaphorum.com
best practice in launch, future of launch excellence, IQVIA, launch approaches, launch excellence
0 Comment
Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand
Orphan medicines launch excellence: sustaining launch success
louise.bellamy@pharmaphorum.com
IQVIA, launch success, orphan medicine launch excellence, orphan medicines, Rare diseases
0 Comment
Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan
louise.bellamy@pharmaphorum.com
ABPI, Brexit, IQVIA, Life Sciences Sector Deal, NHS 10 Year Plan, Pfizer
0 Comment
Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand
Realising the biotech promise: addressing the path to market
louise.bellamy@pharmaphorum.com
Biotech, Brexit, HTA, IQVIA, market access
0 Comment
Debates/ Debates & Insight/ Debates & Insight/ Market Access/ Sales and Marketing/ Webinars in home page/ Webinars On demand
Engaging with HCPS: what do HCPs want from medical meetings?
louise.bellamy@pharmaphorum.com
ashfield, congress management, engagement, HCPs, healthcare events, medical meeting, pharma meetings, Science of meetings, virtual meetings, virtual pharma meetings
0 Comment
Clinical/ Debates & Insight/ Debates & Insights/ Market Access/ R&D/ Veeva channel content articles/ White Papers
New report: Are clinical trials under threat from ‘system overload’?
Adam Jeffery
clinical trial, data, eTMF, patient, PRO, research, Veeva
0 Comment
Debates/ Debates/ Debates & Insight/ Debates & Insight/ Healthcare/ Market Access/ Oncology/ UK & Europe/ Webinars/ Webinars in home page/ Webinars On demand
11/06/2017
Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard
sally.macaulay@pharmaphorum.com
cancer, market access, NHS, pharma, QuinitilesIMS, Vanguard
0 Comment
A unique example of partnership working across the health system, focusses on the service at large, not just the pill, and uses leading-edge data analytics to analyse, benchmark and visualise the current state of the cancer pathways within the Cancer Vanguard Trusts. Furthermore, it encompasses multiple aspects of the service provision ranging from patient outcomes and experiences, the flow of treatment and the usage of medicine in order to inform an evidence-based and patient-centric approach to service redesign and resource optimisation.
Debates/ Debates & Insight/ Healthcare/ Market Access/ UK & Europe/ Webinars/ Webinars in home page/ Webinars On demand
06/09/2017
Pharma and proactive, preventative healthcare: how to use the pharmacy channel
sally.macaulay@pharmaphorum.com
0 Comment
Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare. This webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet this emerging need.